Citation of paper, A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)

Authors Citing This Paper

AuthorCiting PapersAuthor's PapersAuthor's CitationsAuthor's IF
Jocelyn Courville1122
Pilar Nava-Parada1122
John Kelton1122
10
Diogo Mendes1304242.6
Francisco Batel-Marques1275303.4
John E J Rasko119611,4206.4
Qing Shi16553.2
Joana Abrantes1133
Agota Szende17741.6
Myrna Candelaria1111743.1
Ana Penedones1211161.3
Jason Chen110442.5

Journals Citing This Paper